IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Apart from the tests, regarding coupling the TKIs with certain other agents (cl-2 inhibitors, protein synthesis inhibitors, or Peg-IFN) that were referred to multiple times in this paper, other combinations of the existing methods of treatments, or possibly discoveries of new agents, may ultimately aid in finding a cure for CML.